Sanara MedTech Inc.SMTINASDAQ
LOADING
|||
Operating Income Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year operating income growth rate
Latest
9482.54%
↑ 5291% above average
Average (39q)
175.89%
Historical baseline
Range
High:9482.54%
Low:-750.85%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | 9482.54% |
| Q2 2025 | 98.49% |
| Q1 2025 | -454.85% |
| Q4 2024 | 80.52% |
| Q3 2024 | 33.31% |
| Q2 2024 | -88.34% |
| Q1 2024 | -577.76% |
| Q4 2023 | 75.07% |
| Q3 2023 | 51.42% |
| Q2 2023 | -53.43% |
| Q1 2023 | 61.05% |
| Q4 2022 | 3.37% |
| Q3 2022 | 4.52% |
| Q2 2022 | -21.90% |
| Q1 2022 | 18.62% |
| Q4 2021 | -84.05% |
| Q3 2021 | -80.67% |
| Q2 2021 | 5.29% |
| Q1 2021 | -27.17% |
| Q4 2020 | 34.80% |
| Q3 2020 | -21.04% |
| Q2 2020 | 39.88% |
| Q1 2020 | -22.79% |
| Q4 2019 | -83.46% |
| Q3 2019 | -146.72% |
| Q2 2019 | -105.62% |
| Q1 2019 | 66.39% |
| Q4 2018 | -254.22% |
| Q3 2018 | -526.07% |
| Q2 2018 | -53.56% |
| Q1 2018 | 340.29% |
| Q4 2017 | 3.52% |
| Q3 2017 | -124.24% |
| Q2 2017 | 103.78% |
| Q1 2017 | -78.94% |
| Q4 2016 | 27.99% |
| Q3 2016 | 123.92% |
| Q2 2016 | -750.85% |
| Q1 2016 | 135.26% |
| Q4 2015 | -198.58% |